New Enzyme Platform Unlocks Promising Drug Candidates from Natural Sources
Scientists have created a breakthrough enzyme platform that enables cost-effective production of furanolides, a class of natural products demonstrating significant anti-cancer and antibacterial properties. The system allows generation of diverse molecular structures previously inaccessible for drug development research.
Breakthrough in Natural Product Drug Discovery
Researchers have established an innovative enzyme-based platform that reportedly enables efficient production of medically promising natural compounds, according to recently published findings. The system addresses longstanding challenges in accessing sufficient quantities of furanolides, a class of molecules with demonstrated activity against both cancer cells and bacterial pathogens.